FluenTech

Company Overview

Snapshot

Founded in January 2004, FluenTech operates with 1–10 employees. The company focuses on developing rehabilitative and assistive technologies for individuals with speech impediments, holding a patent for its fluency-shaping software.

Business overview

FluenTech develops and commercializes rehabilitative and assistive technologies designed for individuals with speech impediments. Its core product, Dr. Fluency software, offers a PC-based therapy solution for stuttering, integrating patented fluency-shaping software with a comprehensive online home-based training service. This allows users to practice daily to maintain speech volubility and fluency, serving the digital therapeutics and healthcare markets.

Company Intelligence Q&A

What is FluenTech's primary focus?

FluenTech specializes in developing and commercializing rehabilitative and assistive technologies for people with speech impediments, particularly stuttering.

What is the Dr. Fluency software?

Dr. Fluency is a PC-based therapy solution developed by FluenTech for individuals who stutter. It incorporates patented fluency-shaping software and an online home-based training service to help users practice and maintain speech fluency.

When was FluenTech founded?

FluenTech was founded in January 2004.

Does FluenTech hold any patents?

Yes, FluenTech holds a patent related to its fluency-shaping software, which is a key component of its Dr. Fluency solution.

What markets does FluenTech serve?

FluenTech primarily serves the digital therapeutics and healthcare markets, focusing on individuals with speech impediments in Israel.